Literature DB >> 8415687

Modulation of cell proliferation and gene expression by a p53-estrogen receptor hybrid protein.

K Roemer1, T Friedmann.   

Abstract

We report that p53her, a chimeric protein consisting of the complete human wild-type p53 and the human estrogen receptor hormone-binding domain, strongly suppresses proliferation and induces characteristic morphological changes in Saos-2 human osteosarcoma cells when induced by 17 beta-estradiol. In contrast, p53her constitutively transactivates a p53-responsive promoter in transfection assays, so that transactivation is not regulated by estradiol. However, coexpression of p53her and oncoprotein MDM-2, which associates with and presumably inactivates p53, results in suppression of p53her-mediated transactivation in the absence, but not the presence, of estradiol. Similarly, p53her induces expression of an endogenous MDM-2 transcript only in the presence of estradiol. These results suggest a correlation between the growth suppressor function of p53her and release of a transactivation block mediated by MDM-2.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415687      PMCID: PMC47545          DOI: 10.1073/pnas.90.20.9252

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Genetic mechanisms of tumor suppression by the human p53 gene.

Authors:  P L Chen; Y M Chen; R Bookstein; W H Lee
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

2.  Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering.

Authors:  D J Templeton; S H Park; L Lanier; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Guanine nucleotide biosynthesis is regulated by the cellular p53 concentration.

Authors:  J L Sherley
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

4.  Oncogenic forms of p53 inhibit p53-regulated gene expression.

Authors:  S E Kern; J A Pietenpol; S Thiagalingam; A Seymour; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

5.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

6.  Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.

Authors:  J Bartek; R Iggo; J Gannon; D P Lane
Journal:  Oncogene       Date:  1990-06       Impact factor: 9.867

7.  Hormone-dependent transcriptional regulation and cellular transformation by Fos-steroid receptor fusion proteins.

Authors:  G Superti-Furga; G Bergers; D Picard; M Busslinger
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

8.  Identification of p53 as a sequence-specific DNA-binding protein.

Authors:  S E Kern; K W Kinzler; A Bruskin; D Jarosz; P Friedman; C Prives; B Vogelstein
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

9.  Wild-type p53 activates transcription in vitro.

Authors:  G Farmer; J Bargonetti; H Zhu; P Friedman; R Prywes; C Prives
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

10.  Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells.

Authors:  M Eilers; D Picard; K R Yamamoto; J M Bishop
Journal:  Nature       Date:  1989-07-06       Impact factor: 49.962

View more
  8 in total

1.  Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination.

Authors:  C Dudenhöffer; G Rohaly; K Will; W Deppert; L Wiesmüller
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

2.  Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain.

Authors:  D Spengler; M Villalba; A Hoffmann; C Pantaloni; S Houssami; J Bockaert; L Journot
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

3.  DNA substrate dependence of p53-mediated regulation of double-strand break repair.

Authors:  Nuray Akyüz; Gisa S Boehden; Silke Süsse; Andreas Rimek; Ute Preuss; Karl-Heinz Scheidtmann; Lisa Wiesmüller
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

4.  Poly(ADP-ribose) polymerase (PARP-1) and p53 independently function in regulating double-strand break repair in primate cells.

Authors:  Silke Süsse; Claus-Jürgen Scholz; Alexander Bürkle; Lisa Wiesmüller
Journal:  Nucleic Acids Res       Date:  2004-02-02       Impact factor: 16.971

5.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.

Authors:  T D Littlewood; D C Hancock; P S Danielian; M G Parker; G I Evan
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

6.  Ascl1 Coordinately Regulates Gene Expression and the Chromatin Landscape during Neurogenesis.

Authors:  Alexandre A S F Raposo; Francisca F Vasconcelos; Daniela Drechsel; Corentine Marie; Caroline Johnston; Dirk Dolle; Angela Bithell; Sébastien Gillotin; Debbie L C van den Berg; Laurence Ettwiller; Paul Flicek; Gregory E Crawford; Carlos M Parras; Benedikt Berninger; Noel J Buckley; François Guillemot; Diogo S Castro
Journal:  Cell Rep       Date:  2015-03-05       Impact factor: 9.423

7.  Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma.

Authors:  A Suzuki; M Toi; Y Yamamoto; S Saji; M Muta; T Tominaga
Journal:  Jpn J Cancer Res       Date:  1998-02

8.  Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol.

Authors:  S Saji; S Nakashima; S Hayashi; M Toi; S Saji; Y Nozawa
Journal:  Jpn J Cancer Res       Date:  1999-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.